Multiple Sclerosis: Case Studies on the Importance of Early Diagnosis and Optimal Treatment

Saturday, December 20, 2025, 12:00 AM - Tuesday, December 19, 2028, 11:59 PM, On Demand

Internet Enduring Material sponsored by Stanford University School of Medicine. Presented by the Stanford University School of Medicine Department of Neurology and Center for Continuing Medical Education.

Have you encountered a patient with Multiple Sclerosis? This disease affects 2.8 million people worldwide, with a disproportionate number in the United States. In this interactive module about Multiple Sclerosis, explore four case studies that illustrate the importance of early diagnosis and optimal treatment of patients. Providers can learn how to diagnose efficiently and best provide early interventional treatment to Multiple Sclerosis patients.

  Original Release Date: December 20, 2022

  Review Date: June 11, 2025

  Expiration Date: December 19, 2028

  Estimated Time To Complete: 25 minutes

  Registration Fee: FREE

Click Begin to launch the module. View the entire Multiple Sclerosis Series here.

AMA PRA Category 1 Credits™ (0.50 hours), ABIM MOC Part 2 (0.50 hours), Non-Physician Participation Credit (0.50 hours)

1. Apply diagnostic criteria and select appropriate tests used to confirm the diagnosis of MS.
2. Discuss the role of disease-modifying therapy in the management of MS, including the expected benefit, mode of action, and selection of options available.
3. Assess the conditions that should be considered in the differential diagnosis of MS.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine MOC Credit 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MOC Participation Threshold

Learner completes the online workshop, credits will be awarded upon completion.

 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, please contact the CME office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
“An Overview of the Innate Immune System - UpToDate.” Accessed January 25, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/an-overview-of-the-innate-immune-system?search=immunity&sectionRank=1&usage_type=default&anchor=H4039235&source=machineLearning&selectedTitle=1~150&display_rank=1#H4039235. 

“Anaerobic Bacteria: History and Role in Normal Human Flora - UpToDate.” Accessed January 25, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/anaerobic-bacteria-history-and-role-in-normal-human-flora?search=gut%20microbiomes&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H12238507. 

Berer, Kerstin, Lisa Ann Gerdes, Egle Cekanaviciute, Xiaoming Jia, Liang Xiao, Zhongkui Xia, Chuan Liu, et al. “Gut Microbiota from Multiple Sclerosis Patients Enables Spontaneous Autoimmune Encephalomyelitis in Mice.” Proceedings of the National Academy of Sciences of the United States of America 114, no. 40 (October 3, 2017): 10719–24. https://doi.org/10.1073/pnas.1711233114. 

Bhargava, Pavan, and Ellen M. Mowry. “Gut Microbiome and Multiple Sclerosis.” Current Neurology and Neuroscience Reports 14, no. 10 (September 10, 2014): 492. https://doi.org/10.1007/s11910-014-0492-2. 

Chen, Jun, Nicholas Chia, Krishna R. Kalari, Janet Z. Yao, Martina Novotna, M. Mateo Paz Soldan, David H. Luckey, et al. “Multiple Sclerosis Patients Have a Distinct Gut Microbiota Compared to Healthy Controls.” Scientific Reports 6 (June 27, 2016): 28484. https://doi.org/10.1038/srep28484. 

“Clinical Presentation, Course, and Prognosis of Multiple Sclerosis in Adults - UpToDate.” Accessed January 25, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/clinical-presentation-course-and-prognosis-of-multiple-sclerosis-in-adults?search=multiple%20sclersosis&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2. 

Dendrou, Calliope A., Lars Fugger, and Manuel A. Friese. “Immunopathology of Multiple Sclerosis.” Nature Reviews. Immunology 15, no. 9 (September 15, 2015): 545–58. https://doi.org/10.1038/nri3871. 

Esmaeil Amini, Mohammad, Navid Shomali, Arash Bakhshi, Somaye Rezaei, Maryam Hemmatzadeh, Ramin Hosseinzadeh, Solat Eslami, et al. “Gut Microbiome and Multiple Sclerosis: New Insights and Perspective.” International Immunopharmacology 88 (November 1, 2020): 107024. https://doi.org/10.1016/j.intimp.2020.107024. 

Falk, P. G., L. V. Hooper, T. Midtvedt, and J. I. Gordon. “Creating and Maintaining the Gastrointestinal Ecosystem: What We Know and Need to Know from Gnotobiology.” Microbiology and Molecular Biology Reviews: MMBR 62, no. 4 (December 1998): 1157–70. https://doi.org/10.1128/MMBR.62.4.1157-1170.1998. 

“Gastrointestinal Manifestations in Primary Immunodeficiency - UpToDate.” Accessed January 25, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/gastrointestinal-manifestations-in-primary-immunodeficiency?search=gut%20associated%20lymphoid%20tissue&sectionRank=1&usage_type=default&anchor=H17382062&source=machineLearning&selectedTitle=2~24&display_rank=2#H17382062. 

“Immune Functions of Cytokines and Other Immunomodulatory Factors - UpToDate.” Accessed January 25, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/image?imageKey=ALLRG%2F69910&topicKey=ALLRG%2F3980&search=regulatory%20T%20cells&source=see_link. 

“Immunologic Synapse - UpToDate.” Accessed January 25, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/image?imageKey=ENDO%2F69555&topicKey=ALLRG%2F3980&search=regulatory%20T%20cells&source=see_link. 

Jangi, Sushrut, Roopali Gandhi, Laura M. Cox, Ning Li, Felipe von Glehn, Raymond Yan, Bonny Patel, et al. “Alterations of the Human Gut Microbiome in Multiple Sclerosis.” Nature Communications 7 (June 28, 2016): 12015. https://doi.org/10.1038/ncomms12015. 

Lavasani, Shahram, Balik Dzhambazov, Mehrnaz Nouri, Frida Fåk, Sophia Buske, Göran Molin, Henrik Thorlacius, Jan Alenfall, Bengt Jeppsson, and Björn Weström. “A Novel Probiotic Mixture Exerts a Therapeutic Effect on Experimental Autoimmune Encephalomyelitis Mediated by IL-10 Producing Regulatory T Cells.” PloS One 5, no. 2 (February 2, 2010): e9009. https://doi.org/10.1371/journal.pone.0009009. 

Lee, Yun Kyung, Juscilene S. Menezes, Yoshinori Umesaki, and Sarkis K. Mazmanian. “Proinflammatory T-Cell Responses to Gut Microbiota Promote Experimental Autoimmune Encephalomyelitis.” Proceedings of the National Academy of Sciences of the United States of America 108 Suppl 1 (March 15, 2011): 4615–22. https://doi.org/10.1073/pnas.1000082107. 

“Major Histocompatibility Complex (MHC) Structure and Function - UpToDate.” Accessed January 25, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/major-histocompatibility-complex-mhc-structure-and-function?search=mhc&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. 

McCabe, Robert P. “Gastrointestinal Manifestations of Non-AIDS Immunodeficiency.” Current Treatment Options in Gastroenterology 5, no. 1 (February 2002): 17–25. https://doi.org/10.1007/s11938-002-0003-4. 

Miyake, Sachiko, Sangwan Kim, Wataru Suda, Kenshiro Oshima, Masakazu Nakamura, Takako Matsuoka, Norio Chihara, et al. “Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.” PloS One 10, no. 9 (2015): e0137429. https://doi.org/10.1371/journal.pone.0137429. 

Nishida, Kensei, Daisuke Sawada, Yuki Kuwano, Hiroki Tanaka, and Kazuhito Rokutan. “Health Benefits of Lactobacillus Gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study.” Nutrients 11, no. 8 (August 10, 2019): 1859. https://doi.org/10.3390/nu11081859. 

Ochoa-Repáraz, J., D. W. Mielcarz, Y. Wang, S. Begum-Haque, S. Dasgupta, D. L. Kasper, and L. H. Kasper. “A Polysaccharide from the Human Commensal Bacteroides Fragilis Protects against CNS Demyelinating Disease.” Mucosal Immunology 3, no. 5 (September 2010): 487–95. https://doi.org/10.1038/mi.2010.29. 

Ochoa-Repáraz, Javier, Trevor O. Kirby, and Lloyd H. Kasper. “The Gut Microbiome and Multiple Sclerosis.” Cold Spring Harbor Perspectives in Medicine 8, no. 6 (June 1, 2018): a029017. https://doi.org/10.1101/cshperspect.a029017. 

O’Hara, Ann M., and Fergus Shanahan. “The Gut Flora as a Forgotten Organ.” EMBO Reports 7, no. 7 (July 2006): 688–93. https://doi.org/10.1038/sj.embor.7400731. 

“Pathogenesis and Epidemiology of Multiple Sclerosis - UpToDate.” Accessed January 11, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/pathogenesis-and-epidemiology-of-multiple-sclerosis?search=multiple%20sclerosis%20and%20microbiome&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. 

Rumah, Kareem Rashid, Jennifer Linden, Vincent A. Fischetti, and Timothy Vartanian. “Isolation of Clostridium Perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.” PloS One 8, no. 10 (2013): e76359. https://doi.org/10.1371/journal.pone.0076359. 

Säemann, M. D., G. A. Böhmig, C. H. Osterreicher, H. Burtscher, O. Parolini, C. Diakos, J. Stöckl, W. H. Hörl, and G. J. Zlabinger. “Anti-Inflammatory Effects of Sodium Butyrate on Human Monocytes: Potent Inhibition of IL-12 and up-Regulation of IL-10 Production.” FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 14, no. 15 (December 2000): 2380–82. https://doi.org/10.1096/fj.00-0359fje. 

Shahi, Shailesh K., Samantha N. Freedman, and Ashutosh K. Mangalam. “Gut Microbiome in Multiple Sclerosis: The Players Involved and the Roles They Play.” Gut Microbes 8, no. 6 (August 3, 2017): 607–15. https://doi.org/10.1080/19490976.2017.1349041. 

“The Adaptive Cellular Immune Response: T Cells and Cytokines - UpToDate.” Accessed January 25, 2022. https://www-uptodate-com.laneproxy.stanford.edu/contents/the-adaptive-cellular-immune-response-t-cells-and-cytokines?search=regulatory%20T%20cells&topicRef=13933&source=related_link#H47575556. 

Tremlett, Helen, Douglas W. Fadrosh, Ali A. Faruqi, Janace Hart, Shelly Roalstad, Jennifer Graves, Collin M. Spencer, et al. “Associations between the Gut Microbiota and Host Immune Markers in Pediatric Multiple Sclerosis and Controls.” BMC Neurology 16, no. 1 (September 21, 2016): 182. https://doi.org/10.1186/s12883-016-0703-3. 

Wang, Ji, Wei-Dong Chen, and Yan-Dong Wang. “The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages.” Frontiers in Microbiology 11 (2020): 1065. https://doi.org/10.3389/fmicb.2020.01065. 

Wang, Yan, Kiel M. Telesford, Javier Ochoa-Repáraz, Sakhina Haque-Begum, Marc Christy, Eli J. Kasper, Li Wang, et al. “An Intestinal Commensal Symbiosis Factor Controls Neuroinflammation via TLR2-Mediated CD39 Signalling.” Nature Communications 5 (July 21, 2014): 4432. https://doi.org/10.1038/ncomms5432. 

Zhang, Pei, Xiaoli Wu, Shan Liang, Xianfeng Shao, Qianqian Wang, Ruibing Chen, Weimin Zhu, Chen Shao, Feng Jin, and Chenxi Jia. “A Dynamic Mouse Peptidome Landscape Reveals Probiotic Modulation of the Gut-Brain Axis.” Science Signaling, July 28, 2020. https://doi.org/10.1126/scisignal.abb0443.

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

This educational activity is supported in part by an educational grant from Novartis Pharmaceuticals Corporation.